Wilhelm Trentmann

Title: Wilhelm Trentmann: Innovator in Pharmaceutical Chemistry

Introduction

Wilhelm Trentmann is a notable inventor based in Münster, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of high-purity compounds. With a total of five patents to his name, Trentmann's work has had a substantial impact on medical imaging technologies.

Latest Patents

One of Trentmann's latest patents is a method for producing the crystalline form of modification A of calcobutrol. This method describes the production of a high-purity compound starting from gadobutrol. The process involves the removal of gadolinium through decomplexation with oxalic acid, followed by the creation of a calcium complex using a calcium salt. During crystallization, a water equivalent of 9-11 weight % is maintained. The crystalline form of modification A is utilized in the production of Gadovist, a contrast agent used in medical imaging.

Career Highlights

Throughout his career, Trentmann has worked with prominent companies in the pharmaceutical industry. He has been associated with Bayer Intellectual Property GmbH and Bayer Pharma Aktiengesellschaft, where he has contributed to various innovative projects. His expertise in pharmaceutical chemistry has been instrumental in advancing the development of new medical technologies.

Collaborations

Trentmann has collaborated with several professionals in his field, including his coworker Johannes Platzek. These collaborations have fostered an environment of innovation and have led to the successful development of new pharmaceutical methods.

Conclusion

Wilhelm Trentmann's contributions to pharmaceutical chemistry and his innovative patents highlight his role as a key figure in the industry. His work continues to influence the development of medical imaging technologies, showcasing the importance of innovation in healthcare.